Search This Blog

Tuesday, August 4, 2026

Autonomix patent for neuromodulation in nerve sensing, mapping, cancer, organ-function therapies

 

Autonomix Medical announces U.S. Patent No. 12,433,670 for precision neuromodulation in nerve sensing, mapping and targeted cancer and organ-function therapies

  • Patent No. 12,433,670 expands Autonomix Medical's precision neuromodulation intellectual property portfolio.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)